Business Description

Ibogaine treatments have had very high success rate in opioid detoxification. Ibogaine targets multiple receptor sites in the brain, stimulates the production of neural growth factor (enabling the production of new dopamine cells) and resets the central nervous system. Ibogaine’s mission is to treat the roots of addiction effectively using holistic Ibogaine assisted psychotherapy approach.


FRC Analyst's Reports

Universal Ibogaine Inc.-Focused on New Treatment for Opioid Addiction and Other Substances Going Public – Introductory Note Jan. 6, 2021

This company was mentioned in the following "Analysts’ Ideas Of The Week":

Investors are also interested in these companies: